NYSE:IGC
India Globalization Capital Inc Stock News
$0.489
-0.0006 (-0.122%)
At Close: May 24, 2024
IGC Stock: The Huge Cannabis Patent News That Has IGC Flying High
11:44am, Thursday, 22'nd Jul 2021
IGC stock is moving up in a huge way today. The company is finally earning its patent for the treatment of Alzheimer's disease with cannabis.
Top Penny Stocks To Buy Now? 10 To Watch As AMC Volatility Continues
03:26pm, Thursday, 01'st Jul 2021
Which penny stocks are investors watching with AMC back in focus? The post Top Penny Stocks To Buy Now?
Pot Stocks in Focus: Cannabis-Based Pharmaceutical Trials
10:22am, Friday, 25'th Jun 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continue
IGC Completes the Final Cohort of Its Phase 1 Clinical Trial on Alzheimer's Patients
06:50pm, Wednesday, 23'rd Jun 2021
POTOMAC, Md.--(BUSINESS WIRE)-- #IGCAD1--IGC completed Final Cohort of Phase 1 clinical trial on its THC-based investigational new drug intended to alleviate symptoms of Alzheimer's disease.
IGC Reports Financial Results for the Fiscal Year Ended March 31, 2021
06:00pm, Monday, 14'th Jun 2021
POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Reports Financial Results for the Fiscal Year Ended March 31, 2021.
IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients
11:26pm, Monday, 07'th Jun 2021
POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Completes Cohort 2 of its Phase 1 Tetrahydrocannabinol (“THC”)-Based Investigational New Drug Clinical Trial on Alzheimer's Patients.
India Globalization Capital (IGC) Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients
06:01am, Friday, 14'th May 2021
POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients
IGC Receives Another Patent for a Cannabinoid-Based Cream for Treating Pain
06:33pm, Monday, 08'th Mar 2021
POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC got patent (#10,933,082) x its cannabinoid composition & method x treating pain due to Psoriatic Arthritis, Fibromyalgia, Scleroderma & others.
Cannabis Earnings: India Globalization Capital Reports Q3 Results
03:27am, Wednesday, 17'th Feb 2021
The bullish conditions over cannabis stocks remain, although momentum has slowed down. International Globalization Capital works in two different sectors, Materials and Health Care (cannabis).
IGC Commences Phase 1 of Cannabinoid Clinical Trial for Alzheimer's Patients
09:00am, Monday, 23'rd Nov 2020
POTOMAC, MD--(BUSINESS WIRE)-- #AD--India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announced that it is enrolling participants suffering from mild to severe de
POTOMAC, Md.--(BUSINESS WIRE)-- #AD--India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the quarter ended September 30, 2
IGC Reports Financial Results for June 30, 2020 Quarter and Prepares for Phase 1 Cannabinoid Clinical Trial for Alzheimer’s Patients in Puerto Rico.
IGC's stock rallies again, after rocketing fourfold on record volume in the previous session
11:36am, Thursday, 13'th Aug 2020
Shares of India Globalization Capital Inc. surged 26% in premarket trading Thursday, to extend the fourfold rocket ride in the previous session, as they head for an open at the highest level seen dur
India Globalization Surges On CBD Trial For Alzheimer's
01:40pm, Wednesday, 12'th Aug 2020
India Globalization Capital, Inc. (NYSE: IGC) shares are advancing strongly after the company unveiled plans to start an early-stage clinical trial for its cannabinoid, or CBD, formulation.What Happen
FDA Approves Initiation of IGC’s Cannabinoid Trial on Alzheimer’s Patients
09:03pm, Tuesday, 11'th Aug 2020
FDA Approves Initiation of IGC’s Cannabinoid Trial on Alzheimer’s Patients.
